Gerhard Jungwirth

8PUBLICATIONS
63CO-AUTHORS
Molecular targetsHaematological tumoursNeural engineeringPredictive and prognostic markersGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Mar 04, 2026
Drug screening on tumor organoids exposes therapeutic vulnerabilities of meningiomas to HDAC1/2i panobinostat.

Gerhard Jungwirth, Junguo Cao, Yimin Pan

|Dec 31, 2025
Combination tumors of the nervous system: A single-center analysis of a rare condition and comprehensive review of the literature.

Jan Teuber, Abigail K Suwala, David Reuss

|Sep 08, 2023
Effective Reprogramming of Patient-Derived M2-Polarized Glioblastoma-Associated Microglia/Macrophages by Treatment with GW2580.

Valentina Fermi, Rolf Warta, Amélie Wöllner

|May 16, 2023
The Antiepileptic Drug Oxcarbazepine Inhibits the Growth of Patient-Derived Isocitrate Dehydrogenase Mutant Glioma Stem-like Cells.

Philip Dao Trong, Gerhard Jungwirth, Andreas Unterberg

|Oct 25, 2022
Pharmacological Landscape of FDA-Approved Anticancer Drugs Reveals Sensitivities to Ixabepilone, Romidepsin, Omacetaxine, and Carfilzomib in Aggressive Meningiomas.

Gerhard Jungwirth, Tao Yu, Fang Liu

|Dec 10, 2021
Receptor-Tyrosine Kinase Inhibitor Ponatinib Inhibits Meningioma Growth In Vitro and In Vivo.

Tao Yu, Junguo Cao, Montadar Alaa Eddine

Pageof 2

Frequent Collaborators

6 joint publications

Rolf Warta

5 joint publications

Christel Herold-Mende

3 joint publications

Philip Dao Trong

3 joint publications

Mahmoud Moustafa